<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38992068</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2730-664X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Communications medicine</Title><ISOAbbreviation>Commun Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts.</ArticleTitle><Pagination><StartPage>130</StartPage><MedlinePgn>130</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">130</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43856-024-00549-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SARS-CoV-2-infected patients may develop new conditions in the period after the acute infection. These conditions, the post-acute sequelae of SARS-CoV-2 infection (PASC, or Long COVID), involve a diverse set of organ systems. Limited studies have investigated the predictability of Long COVID development and its associated risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective cohort study, we used electronic healthcare records from two large-scale PCORnet clinical research networks, INSIGHT (~1.4 million patients from New York) and OneFlorida+ (~0.7 million patients from Florida), to identify factors associated with having Long COVID, and to develop machine learning-based models for predicting Long COVID development. Both SARS-CoV-2-infected and non-infected adults were analysed during the period of March 2020 to November 2021. Factors associated with Long COVID risk were identified by removing background associations and correcting for multiple tests.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed complex association patterns between baseline factors and a variety of Long COVID conditions, and we highlight that severe acute SARS-CoV-2 infection, being underweight, and having baseline comorbidities (e.g., cancer and cirrhosis) are likely associated with increased risk of developing Long COVID. Several Long COVID conditions, e.g., dementia, malnutrition, chronic obstructive pulmonary disease, heart failure, PASC diagnosis U099, and acute kidney failure are well predicted (C-index&#x2009;&gt;&#x2009;0.8). Moderately predictable conditions include atelectasis, pulmonary embolism, diabetes, pulmonary fibrosis, and thromboembolic disease (C-index 0.7-0.8). Less predictable conditions include fatigue, anxiety, sleep disorders, and depression (C-index around 0.6).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This observational study suggests that association patterns between investigated factors and Long COVID are complex, and the predictability of different Long COVID conditions varies. However, machine learning-based predictive models can help in identifying patients who are at risk of developing a variety of Long COVID conditions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zang</LastName><ForeName>Chengxi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8244-9551</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenck</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Weill Cornell Department of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenxing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2238-5429</Identifier><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozyuk</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khullar</LastName><ForeName>Dhruv</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordvig</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenkman</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Russell L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Block</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyman</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Louisiana Public Health Institute, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yiye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Mark G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-5586-9940</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carton</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Louisiana Public Health Institute, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9459-9461</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. few2001@med.cornell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushal</LastName><ForeName>Rainu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Med (Lond)</MedlineTA><NlmUniqueID>9918250414506676</NlmUniqueID><ISSNLinking>2730-664X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Res Sq. 2023 Mar 08:rs.3.rs-2592194. doi: 10.21203/rs.3.rs-2592194/v1</RefSource><PMID Version="1">36945608</PMID></CommentsCorrections></CommentsCorrectionsList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Most people who develop COVID-19 make a full recovery, but some go on to develop post-acute sequelae of SARS-CoV-2 infection, commonly known as Long COVID. Up to now, we did not know why some people are affected by Long COVID whilst others are not. We conducted a study to identify risk factors for Long COVID and developed a mathematical modeling approach to predict those at risk. We find that Long COVID is associated with some factors such as experiencing severe acute COVID-19, being underweight, and having conditions including cancer or cirrhosis. Due to the wide variety of symptoms defined as Long COVID, it may be challenging to come up with a set of risk factors that can predict the whole spectrum of Long COVID. However, our approach could be used to predict a variety of Long COVID conditions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>11</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38992068</ArticleId><ArticleId IdType="pmc">PMC11239808</ArticleId><ArticleId IdType="doi">10.1038/s43856-024-00549-0</ArticleId><ArticleId IdType="pii">10.1038/s43856-024-00549-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. Accessed July 19, 2022. https://covid19.who.int.</Citation></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. &amp; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 1&#x2013;8. 10.1038/s41591-022-01689-3 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 1&#x2013;10. 10.1038/s41591-022-02116-3 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C, et al. Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative. Nat. Commun. 2023;14:1948. doi: 10.1038/s41467-023-37653-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37653-z</ArticleId><ArticleId IdType="pmc">PMC10080528</ArticleId><ArticleId IdType="pubmed">37029117</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, et al. Risk factors associated with long COVID syndrome: a retrospective study. Iran J. Med. Sci. 2021;46:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, H., Raza, S., Nowell, J., Young, M. &amp; Edison, P. Long Covid&#x2014;mechanisms, risk factors, and management. BMJ. n1648. 10.1136/bmj.n1648 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Oscar M P, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. 2022;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A, Bena J, Pantalone KM, Burguera B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes. Metab. 2021;23:2183&#x2013;2188. doi: 10.1111/dom.14454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14454</ArticleId><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy, F. M., Hairi, N. N., Lim, E. R. J. &amp; Bulgiba, A. Long COVID and its associated factors among COVID survivors in the community from a middle-income country&#x2014;An online cross-sectional study. PLOS ONE17, e0273364 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426885</ArticleId><ArticleId IdType="pubmed">36040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, et al. Launching PCORnet, a national patient-centered clinical research network. J. Am. Med. Inform. Assoc. 2014;21:578&#x2013;582. doi: 10.1136/amiajnl-2014-002747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal R, et al. Changing the research landscape: the New York City Clinical Data Research Network. J. Am. Med. Inform. Assoc. 2014;21:587&#x2013;590. doi: 10.1136/amiajnl-2014-002764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002764</ArticleId><ArticleId IdType="pmc">PMC4078297</ArticleId><ArticleId IdType="pubmed">24821739</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkman E, et al. OneFlorida clinical research consortium: linking a clinical and translational science institute with a community-based distributive medical education model. Acad. Med. 2018;93:451&#x2013;455. doi: 10.1097/ACM.0000000000002029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACM.0000000000002029</ArticleId><ArticleId IdType="pmc">PMC5839715</ArticleId><ArticleId IdType="pubmed">29045273</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar, D. et al. Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-Based cohort study from the RECOVER program. J. Gen. Intern. Med. 38, 1127&#x2013;1136. 10.1007/s11606-022-07997-1 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>About the Initiative | RECOVER COVID Initiative. https://recovercovid.org/ (2024).</Citation></Reference><Reference><Citation>2024 ICD-10-CM Diagnosis Code U09.9: Post COVID-19 condition, unspecified. https://www.icd10data.com/ICD10CM/Codes/U00-U85/U00-U49/U09-/U09.9 (2024).</Citation></Reference><Reference><Citation>Zhang Y, et al. Identifying environmental risk factors for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the recover program. Environ Adv. 2023;11:100352. doi: 10.1016/j.envadv.2023.100352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envadv.2023.100352</ArticleId><ArticleId IdType="pmc">PMC9907788</ArticleId><ArticleId IdType="pubmed">36785842</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma, J. K. et al. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program. PLOS ONE19, e0282451 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11156291</ArticleId><ArticleId IdType="pubmed">38843159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kind AJH, Buckingham WR. Making Neighborhood-disadvantage metrics accessible&#x2014;the neighborhood atlas. N. Engl. J. Med. 2018;378:2456&#x2013;2458. doi: 10.1056/NEJMp1802313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1802313</ArticleId><ArticleId IdType="pmc">PMC6051533</ArticleId><ArticleId IdType="pubmed">29949490</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol. Opt. 2014;34:502&#x2013;508. doi: 10.1111/opo.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/opo.12131</ArticleId><ArticleId IdType="pubmed">24697967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke, G. et al. LightGBM: a highly efficient gradient boosting decision tree. in Advances in Neural Information Processing Systems. Vol. 30. (Curran Associates, Inc.; 2017). Accessed December 5, 2022. https://papers.nips.cc/paper/2017/hash/6449f44a102fde848669bdd9eb6b76fa-Abstract.html.</Citation></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Brentnall AR, Cuzick J. Use of the concordance index for predictors of censored survival data. Stat. Methods Med. Res. 2018;27:2359&#x2013;2373. doi: 10.1177/0962280216680245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216680245</ArticleId><ArticleId IdType="pmc">PMC6041741</ArticleId><ArticleId IdType="pubmed">27920368</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y. &amp; Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol.10, 311&#x2013;321 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sifakis S, Pharmakides G. Anemia in pregnancy. Ann. N Y Acad. Sci. 2000;900:125&#x2013;136. doi: 10.1111/j.1749-6632.2000.tb06223.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06223.x</ArticleId><ArticleId IdType="pubmed">10818399</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromova, O. A., Torshin, I. Y., Shapovalova, Y. O., Kurtser, M. A. &amp; Chuchalin, A. G. COVID-19 and iron deficiency anemia: relationships of pathogenesis and therapy. Obstet. Gynecol. Reprod.14, 644&#x2013;655 (2020).</Citation></Reference><Reference><Citation>Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digital Health. (2022). https://www.thelancet.com/journals/landig/article/PIIS2589-7500 (22)00048-6/fulltext.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo AD, et al. Factors associated with severe COVID-19 among vaccinated adults treated in US Veterans Affairs hospitals. JAMA Netw Open. 2022;5:e2240037. doi: 10.1001/jamanetworkopen.2022.40037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40037</ArticleId><ArticleId IdType="pmc">PMC9585432</ArticleId><ArticleId IdType="pubmed">36264571</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, et al. Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi, P. et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. npj Vaccines7, 1&#x2013;8 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio-Rivas M, et al. WHO ordinal scale and inflammation risk categories in COVID-19. comparative study of the severity scales. J. Gen. Intern. Med. 2022;37:1980&#x2013;1987. doi: 10.1007/s11606-022-07511-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07511-7</ArticleId><ArticleId IdType="pmc">PMC8992782</ArticleId><ArticleId IdType="pubmed">35396659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang, C. calvin-zcx/pasc_phenotype: Code for risk factors and predictive modeling for Long COVID. 10.5281/zenodo.10602738 (2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>